• Intracellular NADH Photocatalysis in Cancer Therapy

  2026-09-01

  This 2025 JACS Perspective examines a catalytic strategy for oxidizing intracellular NADH and NAD(P)H with light-activated metal complexes, thereby disturbing redox balance and cancer-cell metabolism. Its main practical contribution is a framework for evaluating photocatalyst design, cellular controls, metabolic readouts, and the limitations that still separate photocatalytic cancer therapy from clinical use.

• Genotyping Kit for Target Alleles: Assay Strategy

  2026-08-31

  The Genotyping Kit for target alleles supports rapid PCR-ready DNA preparation from diverse biological samples. This article presents an assay-decision framework linking single-tube genotyping to mechanistic studies of intestinal barrier biology without confusing genotype confirmation with functional evidence.

• CGP 55845 hydrochloride Assay Guide

  2026-08-31

  A scenario-based guide to using CGP 55845 hydrochloride (SKU B5086) in GABAB receptor, neurotransmitter-release, and synaptic transmission experiments. It connects assay design, concentration planning, interpretation, and vendor selection to published mechanism and product specifications.

• D-N-Acetylgalactosamine Protocol Guide

  2026-08-30

  D-N-Acetylgalactosamine (SKU B7904) provides a high-purity, water-soluble biochemical reagent for workflows examining glycoprotein constituents, brain heteropolysaccharides, and related glycosylation pathways. It should not be selected for ethanol-based procedures or long-term storage of prepared solutions, so solvent compatibility and fresh-solution handling must be controlled.

• Methotrexate: Folate Antagonist Mechanisms

  2026-08-29

  Methotrexate is a folate antagonist that inhibits DHFR and forms intracellular methotrexate polyglutamates. Its experimental value spans apoptosis induction in activated T cells, immunosuppression, and adenosine release mediated anti-inflammatory mechanisms, but outcomes depend strongly on exposure, cell state, and assay design.

• ECL Western Blotting Substrate: Workflow Guide

  2026-08-29

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for visualizing HRP-labeled proteins on immunoblots. It is intended for chemiluminescent Western blot workflows using X-ray film or CCD cameras, not for fluorescent or radioisotopic detection.

• HCAR3 Cryo-EM Structures Reveal Agonist Selectivity

  2026-08-28

  Ye et al. resolved cryo-EM structures of HCAR3 and HCAR2 bound to multiple agonists, including Acifran, and combined the structural data with cAMP assays to explain receptor recognition and selectivity. The study identifies ligand-pocket occupancy and receptor-specific residue differences that can guide HCAR3-focused lipid metabolism research while highlighting the limits of extrapolating structural observations to therapeutic outcomes.

• Propranolol and Emotional Memory: Meta-Analysis

  2026-08-28

  Lonergan and colleagues quantitatively evaluated whether Propranolol weakens the long-term consolidation or reconsolidation of emotional memories in healthy adults. The findings support a timing-dependent effect on negatively valenced material, while also showing why clinical translation to trauma-related disorders requires further evidence.

• PPM-18 Workflow for iNOS and NF-κB Studies

  2026-08-27

  PPM-18 provides a practical way to separate NF-κB-driven iNOS expression from direct NOS enzyme inhibition in inflammatory models. This workflow shows how to connect nitrite, transcriptional, protein, and nuclear-translocation assays for mechanistic inflammation and sepsis research.

• Vancomycin hydrochloride: Assay Workflows

  2026-08-27

  Turn a mechanistically defined glycopeptide control into a practical platform for Gram-positive susceptibility testing, resistance profiling, and infection-model validation. This guide connects endpoint MIC measurements with time-resolved killing experiments and troubleshooting strategies inspired by adaptive-resistance research.

• CB-839 (Telaglenastat) in Glutaminolysis Assays

  2026-08-26

  CB-839 (Telaglenastat) provides a selective, reversible way to test whether cancer cells depend on GLS1-driven glutaminolysis. This workflow connects metabolite measurements, isotope tracing, viability, and autophagy readouts to mechanistic findings from MYCN-amplified neuroblastoma research.

• Tacrine Hydrochloride Hydrate in AD Research

  2026-08-26

  A metabolism-aware strategy for using Tacrine hydrochloride hydrate to connect cholinesterase pharmacology, cholinergic signaling, neuroprotection, assay rigor, and translational risk in Alzheimer’s disease research.

• 3-Deazaneplanocin (DZNep) Research Workflows

  2026-08-25

  Build reproducible DZNep experiments around SAHH inhibition, EZH2 suppression, apoptosis, and tumor-initiating cell assays. This workflow separates formulation variables from cell-state effects and adapts receptor-stratified assay logic from breast cancer research without overstating DZNep mechanism.

• Liproxstatin-1: Ferroptosis Inhibitor Workflows

  2026-08-25

  Liproxstatin-1 provides a nanomolar rescue tool for separating ferroptotic death from apoptosis and nonspecific oxidative injury. This guide translates its cell and renal-model performance into practical assays for GPX4-deficient protection, lipid-peroxidation measurement, and a hypothesis-driven salivary-gland workflow.

• Amiloride (MK-870): Reliable Assay Workflows

  2026-08-24

  A practical, evidence-based guide to using Amiloride (MK-870), SKU BA2768, in cell viability, proliferation, cytotoxicity, and ion-transport experiments. It connects product handling with assay controls and clarifies why results from cellular endocytosis studies should not be generalized across models.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page